Description

How This Works

Tesamorelin is a synthetic 44‑amino‑acid GHRH analog that stimulates pituitary GH release^[3]. Ipamorelin is a pentapeptide ghrelin mimetic that acts on the GHS‑R1a receptor, selectively stimulating GH secretion without significantly affecting cortisol, prolactin, or ACTH^[4][7]. Combined GHRH + GHRP/ghrelin‑mimetic administration produces synergistic, amplified GH pulses compared to either agent alone^[1][2]. Human pharmacokinetic studies show ipamorelin achieves peak GH release approximately 40 minutes post‑dose^[8].

Potential Benefits & Side Effects

Observations from preclinical and clinical literature.

• Enhanced pulsatile GH secretion through dual‑pathway stimulation^[1][2].
• Tesamorelin (2 mg/day) demonstrated reductions in trunk fat and visceral adipose tissue in HIV‑associated lipodystrophy trials^[3][9].
• Ipamorelin shows high GH selectivity with minimal impact on cortisol or other hormones^[4][7].
• Common adverse events with tesamorelin include injection‑site reactions (erythema, pruritus), arthralgia, and peripheral edema^[5][9].
• Ipamorelin is generally well tolerated; transient flushing or headache may occur^[7].

Lifestyle Factors

Complementary strategies for best outcomes.

• Pair with a balanced, protein‑forward diet tailored to energy needs.
• Combine resistance training and aerobic activity to reinforce metabolic adaptations.
• Prioritize sleep and stress management to support adherence and recovery.
• Evening dosing may align with natural nocturnal GH secretion patterns.